Literature DB >> 26262716

PREVALENCE OF METABOLIC SYNDROME IN YOUNG MEXICANS: A SENSITIVITY ANALYSIS ON ITS COMPONENTS.

Miguel Murguía-Romero1, J Rafael Jiménez-Flores2, Santiago C Sigrist-Flores3, Diana C Tapia-Pancardo4, Arnulfo Jiménez-Ramos5, A René Méndez-Cruz2, Rafael Villalobos-Molina1.   

Abstract

INTRODUCTION: obesity is a worldwide epidemic, and the high prevalence of diabetes type II (DM2) and cardiovascular disease (CVD) is in great part a consequence of that epidemic. Metabolic syndrome is a useful tool to estimate the risk of a young population to evolve to DM2 and CVD.
OBJECTIVE: to estimate the MetS prevalence in young Mexicans, and to evaluate each parameter as an independent indicator through a sensitivity analysis.
METHODS: the prevalence of MetS was estimated in 6 063 young of the México City metropolitan area. A sensitivity analysis was conducted to estimate the performance of each one of the components of MetS, as an indicator of the presence of MetS itself. Five statistical of the sensitivity analysis were calculated for each MetS component and the other parameters included: sensitivity, specificity, positive predictive value or precision, negative predictive value, and accuracy.
RESULTS: the prevalence of MetS in Mexican young population was estimated to be 13.4%. Waist circumference presented the highest sensitivity (96.8% women; 90.0% men), blood pressure presented the highest specificity for women (97.7%) and glucose for men (91.0%). When all the five statistical are considered triglycerides is the component with the highest values, showing a value of 75% or more in four of them. Differences by sex are detected for averages of all components of MetS in young without alterations.
CONCLUSIONS: Mexican young are highly prone to acquire MetS: 71% have at least one and up to five MetS parameters altered, and 13.4% of them have MetS. From all the five components of MetS, waist circumference presented the highest sensitivity as a predictor of MetS, and triglycerides is the best parameter if a single factor is to be taken as sole predictor of MetS in Mexican young population, triglycerides is also the parameter with the highest accuracy. Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26262716     DOI: 10.3305/nh.2015.32.1.9031

Source DB:  PubMed          Journal:  Nutr Hosp        ISSN: 0212-1611            Impact factor:   1.057


  4 in total

1.  B-Cell Activating Factor Increases Related to Adiposity, Insulin Resistance, and Endothelial Dysfunction in Overweight and Obese Subjects.

Authors:  Diana Carolina Villalpando Sánchez; Sergio Gutiérrez Castellanos; Martha Eva Viveros Sandoval; Anel Gómez García
Journal:  Life (Basel)       Date:  2022-04-25

2.  Cardiometabolic risk in young adults from northern Mexico: Revisiting body mass index and waist-circumference as predictors.

Authors:  Abraham Wall-Medrano; Arnulfo Ramos-Jiménez; Rosa P Hernandez-Torres; Rafael Villalobos-Molina; Diana C Tapia-Pancardo; J Rafael Jiménez-Flores; A René Méndez-Cruz; Miguel Murguía-Romero; Itzell A Gallardo-Ortíz; René Urquídez-Romero
Journal:  BMC Public Health       Date:  2016-03-08       Impact factor: 3.295

3.  Evaluation of Anthropometric Indices and Lipid Parameters to Predict Metabolic Syndrome Among Adults in Mexico.

Authors:  Sudip Datta Banik; Elda Pacheco-Pantoja; Roberto Lugo; Lizzette Gómez-de-Regil; Rodolfo Chim Aké; Rosa María Méndez González; Ana Ligia Gutiérrez Solis
Journal:  Diabetes Metab Syndr Obes       Date:  2021-02-16       Impact factor: 3.168

4.  Influence of Single Nucleotide Polymorphisms of ELOVL on Biomarkers of Metabolic Alterations in the Mexican Population.

Authors:  María Luisa Maycotte-Cervantes; Adriana Aguilar-Galarza; Miriam Aracely Anaya-Loyola; Ma de Lourdes Anzures-Cortes; Lorenza Haddad-Talancón; Akram Sharim Méndez-Rangel; Teresa García-Gasca; Víctor Manuel Rodríguez-García; Ulisses Moreno-Celis
Journal:  Nutrients       Date:  2020-11-04       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.